Updates

Access To Drugs Is A Matter Of Life & Death, Mothers of Diabetic Children Testify Before Congress

Jan 30, 2019

At their first hearings of the 116th Congress, the Senate Finance and House Read More

CSRxP Statement On House & Senate Committee Hearings On Skyrocketing Drug Prices

Jan 29, 2019

For Immediate Release: Contact: Lauren Blair (201) 213-5004 lblair@fp1strategies Read More

SHOT/CHASER: Pfizer & Novartis Double-Talk On Price Increases For Drugs Most Important To Bottom Lines

Jan 28, 2019

For Immediate Release: Contact: Lauren Blair (201) 213-5004 lblair@fp1strategies Read More

CSRxP Applauds CMS’s Commitment To Lower Drug Prices

Jan 25, 2019

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today Read More

“WHAT’S PAST IS PROLOGUE” Big Pharma’s Track Record Is A Vast Departure From Its Rhetoric: Part III

Jan 25, 2019

In advance of the House and Senate hearings on January 29, 2019 Read More

“WHAT’S PAST IS PROLOGUE” Big Pharma’s Track Record Is A Vast Departure From Its Rhetoric: Part II

Jan 24, 2019

In advance of the hearing on January 29, 2019, the Campaign for Sustainable Rx Read More

“WHAT’S PAST IS PROLOGUE” Big Pharma’s Track Record Is A Vast Departure From Its Rhetoric: Part I

Jan 23, 2019

For Immediate Release: Contact: Lauren Blair (201) 213-5004 lblair@fp1strategies Read More

Second Opinion: R&D Is Not To Blame For Skyrocketing Drug Costs

Jan 17, 2019

The jig is up – a new report showsthat “the skyrocketing cost of many Read More

CSRxP Welcomes Coalition Against Patent Abuse To Drug Pricing Conversation

Jan 16, 2019

The Campaign for Sustainable Rx Pricing (CSRxP) Communications Director Lauren Read More

Second Opinion: No, Big Pharma Is Not Changing

Jan 11, 2019

Right on cue, dozens of pharmaceutical companies rang in the new year by Read More

With 116th Congress Commencing, CSRxP Announces New Website Launch To Help Lawmakers Address Drug Pricing Crisis

Jan 8, 2019

With ‘taking action to lower drug prices’ becoming Americans’ top Read More

SHOT/CHASER: Analysts Suggest Drug Makers Are Changing Their Ways; Drug Makers Increase Prices By Up To 15 Times Rate Of Inflation

Jan 4, 2019

For Immediate Release Contact: Lauren Blair (201) 213-5004 lblair@fp1strategies. Read More